SYNCOM FORMULATIONS (INDIA)
Back to All Ratios
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
ROCE(%) | 11.05 | 9.68 | 13.72 | 13.28 | 14.72 |
What is the latest Return on Capital Employed (ROCE) ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Return on Capital Employed (ROCE) |
---|---|
Mar2024 | 11.05 |
Mar2023 | 9.68 |
Mar2022 | 13.72 |
Mar2017 | 13.28 |
Mar2016 | 14.72 |
How is Return on Capital Employed (ROCE) of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Return on Capital Employed (ROCE) | % Change | |
---|---|---|---|
Mar2024 | 11.05 | 14.15 | |
Mar2023 | 9.68 | -29.45 | |
Mar2022 | 13.72 | 3.31 | |
Mar2017 | 13.28 | -9.78 | |
Mar2016 | 14.72 | - |
Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,003.1 Cr | -3.3% | 21.7% | 73.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -3.3% |
21.7% |
73.7% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses